follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Actavis acquiring Warner Chilcott in all-stock deal

By

Back to Top Comments Print

Latest News

advertisement

Parsippany-based Actavis Inc. announced today it will acquire Warner Chilcott PLC in a $5 billion stock swap that’s expected to create a specialty pharmaceuticals company with about $11 million in annual revenue.

Actavis said it will swap 0.16 of a share for each Chilcott share, valuing the Chilcott shares at about $20.08 each. The deal is expected to close by the end of the year.

The new company, Actavis PLC, will be led by the current Actavis leadership team, the company said.

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top